<?xml version="1.0" ?>
<document id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19">
  <chunk id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c0" text="A Reverse Genetics Platform That Spans the Zika Virus Family Tree"/>
  <chunk id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1" text="Zika virus (ZIKV), a mosquito-borne flavivirus discovered in 1947, has only recently caused large outbreaks and emerged as a significant human pathogen. In 2015, ZIKV was detected in Brazil, and the resulting epidemic has spread throughout the Western Hemisphere. Severe complications from ZIKV infection include neurological disorders such as Guillain-BarrÃ© syndrome in adults and a variety of fetal abnormalities, including microcephaly, blindness, placental insufficiency, and fetal demise. There is an urgent need for tools and reagents to study the pathogenesis of epidemic ZIKV and for testing vaccines and antivirals. Using a reverse genetics platform, we generated six ZIKV infectious clones and derivative viruses representing diverse temporal and geographic origins. These include three versions of MR766, the prototype 1947 strain (with and without a glycosylation site in the envelope protein), and H/PF/2013, a 2013 human isolate from French Polynesia representative of the virus introduced to Brazil. In the course of synthesizing a clone of a circulating Brazilian strain, phylogenetic studies identified two distinct ZIKV clades in Brazil. We reconstructed viable clones of strains SPH2015 and BeH819015, representing ancestral members of each clade. We assessed recombinant virus replication, binding to monoclonal antibodies, and virulence in mice. This panel of molecular clones and recombinant virus isolates will enable targeted studies of viral determinants of pathogenesis, adaptation, and evolution, as well as the rational attenuation of contemporary outbreak strains to facilitate the design of vaccines and therapeutics.">
    <entity charOffset="264-270" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e0" ontology_id="HP_0012828" text="Severe" type="phenotype"/>
    <entity charOffset="554-566" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e1" ontology_id="GO_0009405" text="pathogenesis" type="gene_function"/>
    <entity charOffset="862-875" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e2" ontology_id="GO_0070085" text="glycosylation" type="gene_function"/>
    <entity charOffset="888-896" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e3" ontology_id="GO_0031975" text="envelope" type="gene_function"/>
    <entity charOffset="1310-1317" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e4" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="1483-1495" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e5" ontology_id="GO_0009405" text="pathogenesis" type="gene_function"/>
    <pair e1="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e0" e2="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e1" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.p0" relation="true"/>
    <pair e1="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e0" e2="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e2" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.p1" relation="true"/>
    <pair e1="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e0" e2="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e3" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.p2" relation="true"/>
    <pair e1="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e0" e2="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e4" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.p3" relation="true"/>
    <pair e1="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e0" e2="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.e5" id="99f6ca41bcf6a11e4a3c722d5e00a9bfec79ca19.c1.p4" relation="true"/>
  </chunk>
</document>
